WO2001094532A3 - Nouveau polypeptide, proteine ribosomale l39 9, et polynucleotide codant ce polypeptide - Google Patents
Nouveau polypeptide, proteine ribosomale l39 9, et polynucleotide codant ce polypeptide Download PDFInfo
- Publication number
- WO2001094532A3 WO2001094532A3 PCT/CN2001/000820 CN0100820W WO0194532A3 WO 2001094532 A3 WO2001094532 A3 WO 2001094532A3 CN 0100820 W CN0100820 W CN 0100820W WO 0194532 A3 WO0194532 A3 WO 0194532A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptide
- polynucleotide encoding
- ribosomal protein
- discloses
- novel
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 102100035988 60S ribosomal protein L39 Human genes 0.000 title abstract 3
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 108010025387 ribosomal protein L39 Proteins 0.000 title abstract 3
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne un nouveau polypeptide, une protéine ribosomale L39 9, et un polynucléotide codant ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant la protéine ribosomale L39 9.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU89479/01A AU8947901A (en) | 2000-05-24 | 2001-05-21 | A novel polypeptide, ribosomal protein l39 9 and the polynucleotide encoding thepolypeptide |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00115815 CN1324810A (zh) | 2000-05-24 | 2000-05-24 | 一种新的多肽——核糖体l39蛋白9和编码这种多肽的多核苷酸 |
| CN00115815.5 | 2000-05-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001094532A2 WO2001094532A2 (fr) | 2001-12-13 |
| WO2001094532A3 true WO2001094532A3 (fr) | 2002-02-28 |
Family
ID=4585257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2001/000820 WO2001094532A2 (fr) | 2000-05-24 | 2001-05-21 | Nouveau polypeptide, proteine ribosomale l39 9, et polynucleotide codant ce polypeptide |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1324810A (fr) |
| AU (1) | AU8947901A (fr) |
| WO (1) | WO2001094532A2 (fr) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997048797A1 (fr) * | 1996-06-17 | 1997-12-24 | Genzyme Corporation | Nouveaux genes du chromosome 16 humain, leurs compositions, et leurs procedes de production et d'utilisation |
| WO2000028079A2 (fr) * | 1998-11-09 | 2000-05-18 | Gemini Genomics Ab | Variation genetique associee a l'anemie aplasique, et applications diagnostiques et therapeutiques basees sur cette variation |
-
2000
- 2000-05-24 CN CN 00115815 patent/CN1324810A/zh active Pending
-
2001
- 2001-05-21 AU AU89479/01A patent/AU8947901A/en not_active Abandoned
- 2001-05-21 WO PCT/CN2001/000820 patent/WO2001094532A2/fr active Application Filing
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997048797A1 (fr) * | 1996-06-17 | 1997-12-24 | Genzyme Corporation | Nouveaux genes du chromosome 16 humain, leurs compositions, et leurs procedes de production et d'utilisation |
| WO2000028079A2 (fr) * | 1998-11-09 | 2000-05-18 | Gemini Genomics Ab | Variation genetique associee a l'anemie aplasique, et applications diagnostiques et therapeutiques basees sur cette variation |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001094532A2 (fr) | 2001-12-13 |
| CN1324810A (zh) | 2001-12-05 |
| AU8947901A (en) | 2001-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001094532A3 (fr) | Nouveau polypeptide, proteine ribosomale l39 9, et polynucleotide codant ce polypeptide | |
| WO2001075048A3 (fr) | Nouveau polypeptide, proteine ribosomale humaine s11 23, et polynucleotide codant pour ce polypeptide | |
| WO2001075036A3 (fr) | Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide | |
| WO2002000821A3 (fr) | Nouveau polypeptide, proteine humaine plp 39, et polynucleotide codant ce polypeptide | |
| WO2001075057A3 (fr) | Nouveau polypeptide, proteine ribosomale s4 humaine 12, et polynucleotide codant pour ce polypeptide | |
| WO2001064866A1 (fr) | Nouveau polypeptide, ribosome s19e 11, et polynucleotide codant pour ce polypeptide | |
| WO2001075028A3 (fr) | Nouveau polypeptide, proteine ribosomale humaine s4-12, et polynucleotide codant pour ce polypeptide | |
| WO2001075011A3 (fr) | Nouveau polypeptide, proteine humaine de constitution 10 de cytochromes, et polynucleotide codant pour ce polypeptide | |
| WO2001075016A3 (fr) | Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide | |
| WO2002000828A3 (fr) | Nouveau polypeptide, proteine a doigt de zinc 34, et polynucleotide codant ce polypeptide | |
| WO2001075061A3 (fr) | Nouveau polypeptide, cdv-1-42, et polynucleotide codant pour ce polypeptide | |
| WO2002000823A3 (fr) | Nouveau polypeptide, proteine d'activation enzymatique ras gtp 9.57, et polynucleotide codant ce polypeptide | |
| WO2001075034A3 (fr) | Nouveau polypeptide, peroxydase proteine humaine 15, et polynucleotide codant pour ce polypeptide | |
| WO2001075035A3 (fr) | Nouveau polypeptide, peroxydase proteine humaine 9, et polynucleotide codant pour ce polypeptide | |
| WO2001083681A3 (fr) | Nouveau polypeptide, dihydroorotase humaine 21, et polynucleotide codant pour ce polypeptide | |
| WO2001075007A3 (fr) | Nouveau polypeptide, tyrosinase 15, et polynucléotide codant pour ce polypeptide | |
| WO2001075058A3 (fr) | Nouveau polypeptide, aminoacyl-arnt synthetase humaine 15 de type ii, et polynucleotide codant pour ce polypeptide | |
| WO2001075004A3 (fr) | Nouveau polypeptide, enzyme de conjugaison de l'ubiquitine 9, et polynucléotide codant pour ce polypeptide | |
| WO2001083687A3 (fr) | Nouveau polypeptide, proteine pax humaine 23, et polynucleotide codant pour ce polypeptide | |
| WO2001079431A3 (fr) | Nouveau polypeptide, proteine humaine d'interaction 15 avec la proteine huntingtine, et polynucleotide codant pour ce polypeptide | |
| WO2001075002A3 (fr) | Nouveau polypeptide, gène de regulation du cycle cellulaire humain 28, et polynucléotide codant pour ce polypeptide | |
| WO2001077285A3 (fr) | Nouveau polypeptide, proteine 13 de la famille des amidases, et polynucleotide codant pour ce polypeptide | |
| WO2001077287A3 (fr) | Nouveau polypeptide, globine humaine de l'uterus 11, et polynucleotide codant pour ce polypeptide | |
| WO2001083682A3 (fr) | Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide | |
| WO2001075006A3 (fr) | Nouveau polypeptide, chaîne légere de protéine réseau 37, et polynucléotide codant pour ce polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |